Tesofensine is a novel triple monoamine reuptake inhibitor that was originally developed for the treatment of neurodegenerative disorders like Parkinson’s and Alzheimer’s disease. During a Phase II clinical trial, however, its potent weight loss effect became the primary focus of…
Tesofensine sits in a fascinating corner of life sciences, where brain chemistry collides with metabolism and behavior. It is being studied not just as another entry in the long list of weight loss drugs, but as a compound that may…
Tesofensine is a potent triple monoamine reuptake inhibitor (TRI) currently being investigated for its potential in treating obesity and metabolic disorders. Developed for conditions like Alzheimer’s disease and Parkinson’s, it acts as a high-affinity reuptake inhibitor that enhances neuronal activity.…
Tesofensine is not broadly available as an FDA-approved prescription medication in the United States. That means in most ordinary consumer settings, you are not walking into a pharmacy and filling a standard tesofensine prescription the way you would with blood…
Tesofensine is a potent compound that inhibits the reuptake of dopamine, serotonin, and norepinephrine. Because it acts directly on the central nervous system (CNS), its interaction with alcohol—a known CNS depressant—is a topic of significant concern in clinical research. As…
All products on this website are sold strictly for in vitro research and laboratory use only.
By clicking "Accept," you confirm:
